ADVERTISEMENTs

Purvesh Khatri’s immune scoring system can guide critical care decisions

Findings from the Stanford study showed that patients with high lymphoid dysregulation often benefited from steroid treatments, improving survival rates.

Purvesh Khatri / Stanford Medicine

Stanford Medicine researcher Purvesh Khatri has developed a blood-based scoring system that could help doctors quickly decide how to treat patients with life-threatening conditions such as sepsis, trauma, burns, or respiratory distress. Khatri, an Indian-origin professor of biomedical informatics, detailed the findings in two papers published in Nature Medicine on Sept. 30.

The research builds on earlier work showing that immune cell gene “signatures” can diagnose infections and predict severity. This year, the U.S. Food and Drug Administration cleared a clinical test, known as TriVerity, based on those findings. TriVerity measures the activity of 29 genes to determine the likelihood of bacterial or viral infection and whether a patient is likely to require intensive care.

ALSO READ: Indian-origin scientist identifies immune cells linked to chronic inflammation and aging

 

This post is for paying subscribers only

SUBSCRIBE NOW

Comments

Related